TransGenic Group

TransGenic Group ROE

The Return on Equity (ROE) of TransGenic Group (2342.T) as of Sep 27, 2026 is -1.62 %. In the previous year, Return on Equity (ROE) was -22.88 % — a change of -92.93% (higher).

ROE

-1.62 %

YoY

-92.93%

Last updated:

In 2026, TransGenic Group's return on equity (ROE) was -1.62 %, a -92.93% increase from the -22.88 % ROE in the previous year.

The TransGenic Group ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
4.14 JPY
Jan 1, 2020
-9.98 JPY
Jan 1, 2021
11.11 JPY
Jan 1, 2022
28.72 JPY
Jan 1, 2023
-6.81 JPY
Jan 1, 2024
0.07 JPY
Jan 1, 2025
-22.88 JPY
Jan 1, 2026
-1.62 JPY
The TransGenic Group ROE history
YEARROEYoY
-1.62 %-92.93%
-22.88 %-33,110.63%
0.07 %-101.02%
-6.81 %-123.70%
28.72 %+158.49%
11.11 %-211.35%
-9.98 %-341.14%
4.14 %+759.75%
0.48 %-81.07%
2.54 %+435.14%
0.48 %-25.96%
0.64 %-115.32%
-4.19 %—
Access this data via the Eulerpool API
Get Free API Key

TransGenic Group Stock analysis

What does TransGenic Group do? TransGenic Group is one of the most popular companies on Eulerpool.

ROE Details

Decoding TransGenic Group's Return on Equity (ROE)

TransGenic Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing TransGenic Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

TransGenic Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in TransGenic Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about TransGenic Group stock

Return on Equity (ROE) of TransGenic Group is -1.62 % in 2026.

Return on Equity (ROE) of TransGenic Group changed from -22.88 % to -1.62 %, representing a -92.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) TransGenic Group since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s TransGenic Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — TransGenic Group

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — TransGenic Group